In a recent article from Forbes, the worst performing biotech stocks from 2013 were listed. Of the companies that posted negative results, the worst damage came to those that presented bad clinical data or had run-ins with the U.S. Food and Drug Administration.
The Worst-Performing Biotech Stocks of 2013
CLSN Celsion Corporation 52.9 -89.4
ASTM Aastrom Biosciences, Inc. 14.1 -87.2
DCTH Delcath Systems, Inc. 32.2 -79.3
CVM CEL-SCI Corporation 28.9 -78.1
AVEO AVEO Pharmaceuticals, Inc. 94.9 -77.3
AMRN Amarin Corporation Plc Sponsored ADR 340.1 -75.6
ENZN Enzon Pharmaceuticals, Inc. 51.1 -73.8
ZLCS Zalicus Inc. 29.0 -71.5
ECTE Echo Therapeutics, Inc. 33.1 -69.8
SPHS Sophiris Bio Inc. 59.8 -68.9
PBMD Prima Biomed Ltd Sponsored ADR 45.1 -68.6
PTX Pernix Therapeutics Holdings, Inc. 93.7 -67.5
OXBT Oxygen Biotherapeutics, Inc. 47.8 -65.1
ARIA ARIAD Pharmaceuticals, Inc. 1,266.2 -64.4
GTXI GTx, Inc. 104.3 -60.7
INFI Infinity Pharmaceuticals, Inc. 664.1 -60.5
ONCY Oncolytics Biotech Inc. 131.4 -60.5
VICL Vical Incorporated 102.4 -59.5
BAXS Baxano Surgical, Inc. 45.6 -59.3
ACHN Achillion Pharmaceuticals, Inc. 320.8 -58.6
BTK AMEX Biotechnology Index 0.0 50.6
If your broker/financial advisor recommend any of these biotechs and did lost more than $50,000, call for a free consultation with an attorney on how to potentially recover your investment losses: 888-760-6552. Soreide Law Group represents clients nationwide in arbitrations before FINRA.
Investors apparently complained about securities broker Matthew Robert Westberry (also known as Matt Westberry) [CRD: 4908745, Marion, Iowa], based on public information on Financial Industry Regulatory Authority (FINRA) BrokerCheck. Westberry worked for SCF Securities Inc. from February 28, 2022, to October 23, 2024, and previously worked for LPL Financial LLC from August 10, 2018, to […]
Investors may have suffered financial harm by securities broker Joseph Anthony Monaco Jr. [CRD: 1398158, Melville, New York], given the public information found on Financial Industry Regulatory Authority (FINRA) BrokerCheck. Monaco worked for Oppenheimer Co. Inc. from June 7, 2023, to December 6, 2024, and previously worked for Stifel Nicolaus from June 25, 2014, to […]
Investors potentially experienced sales practice violations by securities broker Scott Thomas Schaul [CRD: 2200484, Attleboro, Massachusetts], based on publicly available information on Financial Industry Regulatory Authority (FINRA) BrokerCheck. Schaul worked for Essex Securities LLC from March 22, 2010, to August 6, 2019, Pinnacle Investments LLC from June 28, 2019, to April 13, 2026, and has […]
Phone:
Fax: 1-954-760-6553
Email: info@securitieslawyer.com